Delayed Diagnosis Common in Spinal Ailment Typical 7-year delay after symptom onset leaves patients at risk for irreversible damage Apr 30, 2021
Perianal Involvement in Crohn’s Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
In Lupus, Even Minor Changes in Disease Activity Matter One-unit increase in disease activity score raised mortality risk by 22%, study showed Apr 14, 2021
Pegloticase Safe for Dialysis Patients With Gout Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
FDA Panel Unhappy With Novel OA Pain Drug Latest setback for troubled osteoarthritis biologic Mar 25, 2021
Serious Infections Still Common in Vasculitis Cyclophosphamide induction was riskier than rituximab Mar 23, 2021
What to Tell Patients With Rheumatic/Musculoskeletal Diseases About COVID Vaccines New guidance from the American College of Rheumatology Mar 19, 2021
Vasculitis Rates Rise With Earth's Latitude Highest rates for giant cell arteritis seen in Scandinavia, lowest in Hong Kong Mar 17, 2021
Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
Don't Stop Taltz in Psoriatic Arthritis Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemia Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
Combo Therapy Boosts Response in Uncontrolled Gout "Markedly higher" rate than with pegloticase alone Mar 02, 2021
Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
JAK Inhibitor a Hit With RA Patients Superior to adalimumab on many patient-reported outcomes Feb 26, 2021
Anakinra for Gout Flares: Is There a Role? IL-1 blockade was not superior to triamcinolone, but does have advantages Feb 23, 2021
Lung Hemorrhage in Lupus: Which Patients Die? Risk factors include older age, longer disease duration, infection, and certain treatments Feb 20, 2021
Avacopan for ANCA Vasculitis: A New Treatment Paradigm? Remission rates not inferior to prednisone -- the "unthinkable" achieved Feb 17, 2021
Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
Opioids Concerningly Common for Diabetic Nerve Pain But overall prescriptions for pain meds have tapered off over the years Jan 28, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home But some find science-by-press-release troubling Jan 26, 2021
IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
Staying Safe in Lupus: Monitor Hydroxychloroquine Levels Limit the retinopathy risk while maintaining anti-thrombotic protection, study suggests Jan 11, 2021
Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
PET Scans Reveal Vascular Inflammation In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
Who Flares When SLE Patients Stop Hydroxychloroquine? Flares more likely among minorities, younger patients, and those taking steroids Jan 05, 2021
Spinal Benefits Seen With Cosentyx in PsA First trial to evaluate response of axial symptoms in psoriatic arthritis to biologic treatment Dec 22, 2020
Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
More Evidence Early Mortality Persists in IBD Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
COVID Complications Common with Rheumatic Disease Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
Rinvoq for RA: Benefits Persist Beyond 1 Year Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
